Abstract

BackgroundAntimalarials (AM) have been related to a lower risk and severity of infections in systemic lupus erythematosus [1], but in rheumatoid arthritis (RA) the results are not unanimously favorable to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call